These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 22161581

  • 21. Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.
    Filippi L, Tamburini A, Berti E, Perrone A, Defilippi C, Favre C, Calvani M, Della Bona ML, la Marca G, Donzelli G.
    Pediatr Blood Cancer; 2016 Jul; 63(7):1290-2. PubMed ID: 27100060
    [Abstract] [Full Text] [Related]

  • 22. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Wang Z, Li K, Dong K, Xiao X, Zheng S.
    Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
    [No Abstract] [Full Text] [Related]

  • 23. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
    Zaidi SJ, Shaik S, Agrawal C, Cossor W.
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):536-540. PubMed ID: 30067556
    [Abstract] [Full Text] [Related]

  • 24. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
    Alonso Arroyo V, Lopez-Gutierrez JC, Martinez R, Fernandez-Pineda I.
    Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
    [Abstract] [Full Text] [Related]

  • 25. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
    López V, Martí N, Pereda C, Martín JM, Ramón D, Mayordomo E, Jordá E.
    Pediatr Dermatol; 2009 May; 26(3):365-6. PubMed ID: 19706115
    [Abstract] [Full Text] [Related]

  • 26. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
    Der Sarkissian SA, Wong XL, Kossard S, Hong A, Sebaratnam DF.
    Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
    [Abstract] [Full Text] [Related]

  • 27. Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma.
    Liu X, Li J, Qu X, Yan W, Zhang L, Zhang S, Yang C, Zheng J.
    Medicine (Baltimore); 2016 May; 95(20):e3431. PubMed ID: 27196448
    [Abstract] [Full Text] [Related]

  • 28. Pneumocystis jirovecii pneumonia: A potential complication of sirolimus therapy.
    Shetty AK.
    J Paediatr Child Health; 2019 Apr; 55(4):484. PubMed ID: 30957331
    [No Abstract] [Full Text] [Related]

  • 29. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H, Guo X, Duan Y, Zheng B, Gao Y.
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [Abstract] [Full Text] [Related]

  • 30. Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.
    del Pozo J, López-Gutiérrez JC, Gómez-Tellado M, Nistal M, Soler R, Sacristán F, Tovar JA.
    Pediatr Dermatol; 2011 Sep; 28(4):439-43. PubMed ID: 20403115
    [Abstract] [Full Text] [Related]

  • 31. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H, Ozeki M, Hori T, Kanda K, Kawamoto N, Nagano A, Azuma E, Miyazaki T, Fukao T.
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [Abstract] [Full Text] [Related]

  • 32. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
    MacFarland SP, Sullivan LM, States LJ, Bailey LC, Balamuth NJ, Womer RB, Olson TS.
    J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
    [Abstract] [Full Text] [Related]

  • 33. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
    Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K, Winkler B.
    J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
    [No Abstract] [Full Text] [Related]

  • 34. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma.
    Liu YX, Zhang J, Nie XL, Chen YL, Wang ZY, Xu ZG.
    Australas J Dermatol; 2021 May; 62(2):e329-e331. PubMed ID: 33216947
    [No Abstract] [Full Text] [Related]

  • 35. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W, Li K, Wang Z, Dong K, Zheng S.
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [Abstract] [Full Text] [Related]

  • 36. Congenital fulminant Kaposiform hemangioendothelioma of the leg.
    Ergaz Z, Bar-Oz B, Vainer GW, Abu-Leil S, Simanovsky N, Diav-Citrin O.
    Reprod Toxicol; 2014 Dec; 50():1-3. PubMed ID: 25277314
    [Abstract] [Full Text] [Related]

  • 37. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S, Cassarino DS.
    JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract] [Full Text] [Related]

  • 38. A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus.
    Wlodek C, Burt H, Shaw L.
    Clin Exp Dermatol; 2017 Oct; 42(7):825-827. PubMed ID: 28703334
    [No Abstract] [Full Text] [Related]

  • 39. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon.
    Zhang G, Gao Y, Liu X.
    Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059
    [No Abstract] [Full Text] [Related]

  • 40. Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon.
    Das A, Bansal D, Chatterjee D, Das A.
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):153-154. PubMed ID: 27820128
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.